Clinical trials
Phase 1/2 Agnosia trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
25 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 1 |
| 2010 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 3 |
| 2026 | 6 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Recruiting | 4 |
| Not yet recruiting | 3 |
| Active, not recruiting | 2 |
| Terminated | 2 |
| Unknown status | 2 |
| Withdrawn | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| David Chi, MD | 2 |
| University of Maryland, Baltimore | 2 |
| Azad University of Medical Sciences | 1 |
| CAMC Health System | 1 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 1 |
| East Carolina University | 1 |
| Federal University of Latin American Integration | 1 |
| Florida A&M University | 1 |
| Heron Therapeutics | 1 |
| Hospital Universitario La Fe | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Agnosia | 25 |
| Pain | 7 |
| Postoperative Pain | 6 |
| Diverticular Diseases | 2 |
| Fibromyalgia | 2 |
| Neoplasms | 2 |
| Acute Pain | 1 |
| Appendicitis | 1 |
| Bunion | 1 |
| Cardiovascular Diseases | 1 |
Trials
Showing 26 to 25 of 25. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.